Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Friday, November 27, 2009, 7:49PM ET - U.S. Markets closed early today. Dow Down 1.48% Nasdaq Down 1.73%
Nymox Pharmaceutical Corporation (NYMX)At 12:57PM ET: 4.39  Down 0.15 (3.30%)  
MORE ON NYMX
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Mon, Nov 23, 2009
Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for Early Responders to Company's BPH Drug NX-1207
GlobeNewswire (Mon, Nov 23)
Fri, Nov 13, 2009
Nymox Reports Third Quarter 2009 Financial Results
GlobeNewswire (Fri, Nov 13)
Piper Jaffray Senior Research Analyst Sees M&A Activity As Brisk As Foreign Companies Seek US Specialty Pharmaceutical Distribution Networks
Wall Street Transcript (Fri, Nov 13)
Wed, Oct 14, 2009
Nymox's NX-1207 to be Clinically Tested for Prostate Cancer
GlobeNewswire (Wed, Oct 14)
Mon, Oct 5, 2009
Nymox Announces New Pooled Analysis Confirms 12 Month Benefit of NX-1207 Treatment for BPH
GlobeNewswire (Mon, Oct 5)
Wed, Aug 26, 2009
Nymox's NX-1207 Shows Major Effect On Liver Cancer
GlobeNewswire (Wed, Aug 26)
Fri, Aug 14, 2009
Nymox Reports Second Quarter 2009 Financial Results
GlobeNewswire (Fri, Aug 14)
Wed, Jun 24, 2009
9 Stocks to Shake the Market
at Motley Fool (Wed, Jun 24)
Tue, Jun 2, 2009
Nymox Announces Dosing of First Patient in Phase 3 Trial for NX-1207 for BPH
GlobeNewswire (Tue, Jun 2)
Fri, May 15, 2009
Nymox Reports First Quarter 2009 Financial Results
GlobeNewswire (Fri, May 15)
Tue, May 5, 2009
Nymox Announces Start of Second Phase 3 Trial for NX-1207 for BPH
GlobeNewswire (Tue, May 5)
Tue, Apr 21, 2009
Nymox Reports Initiation of Phase 3 Trials for NX-1207 for BPH
GlobeNewswire (Tue, Apr 21)
Fri, Mar 20, 2009
NYMOX PHARMACEUTICAL CORP Financials
EDGAR Online Financials (Fri, Mar 20)
Fri, Mar 13, 2009
Nymox Reports 2008 Financial Results
GlobeNewswire (Fri, Mar 13)
Tue, Feb 24, 2009
Nymox Announces New Positive Results At 5 Years After Single Treatment in Long Term Study of NX-1207 for Benign Prostatic Hyperplasia
GlobeNewswire (Tue, Feb 24)
Wed, Feb 18, 2009
Nymox Provides Update On Pivotal Phase 3 Trials for BPH Drug
GlobeNewswire (Wed, Feb 18)
Tue, Jan 13, 2009
Nymox Releases Positive New Clinical Trial Data On Durability of Response Rates to Company's BPH Drug NX-1207
GlobeNewswire (Tue, Jan 13)
Thu, Jan 8, 2009
Third Hand Smoke Recognized as Health Hazard
GlobeNewswire (Thu, Jan 8)
Tue, Dec 30, 2008
Nymox Announces $15 Million Equity Financing Commitment
GlobeNewswire (Tue, Dec 30)
Fri, Dec 19, 2008
Nymox NX-1207 Successful Clinical Trial Results Featured in Urology Times
GlobeNewswire (Fri, Dec 19)
Older Headlines - Download Recent Headlines
View headlines from:
Add NYMX News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage